Who Is Michele Kang? Age, Biography and Wiki
Michele Kang was born on June 1, 1959, making her 65 years old as of 2025. She has garnered recognition for her entrepreneurial spirit, leadership roles, and dedication to advancing health technology. Kang is the founder and CEO of Cognate Health, a leading biotechnology firm focused on cell therapy and regenerative medicine. Her journey from humble beginnings to becoming a powerhouse in the industry is a testament to her hard work and vision.
| Occupation | Business Executive |
|---|---|
| Date of Birth | June 1, 1959 |
| Age | 66 Years |
| Birth Place | South Korea |
| Horoscope | Gemini |
| Country | South Korea |
Popularity
Michele Kang's Popularity over time
Height, Weight & Measurements
Michele Kang maintains a healthy lifestyle, which reflects in her physical appearance. As of 2025, her height is approximately 5 feet 6 inches (168 cm), and she weighs around 130 pounds (59 kg). While precise measurements may vary, Kang is known for her fit physique, which aligns with her commitment to well-being.
Family, Dating & Relationship Status
Michele Kang is known to keep her personal life private. As of 2025, she is believed to be currently single, focusing on her career and professional growth. There are no public records or reports indicating any long-term relationships or a significant other. Kang prefers to maintain a low profile regarding her dating life, choosing instead to channel her energy into her business endeavors.
Born and raised in Seoul, South Korea, Kang attended the Ewha Womans University. During her first year of business administration studies at the Sogang University in 1980, the student-led protest for democracy, the Gwangju Uprising, broke out, which prompted her to move to the United States.
Using her parents' savings for her future marriage, she entered the University of Chicago, and graduated in economics. She then obtained her master's degree in public and private management (MPPM) from the Yale School of Management.
Net Worth and Salary
As a successful businesswoman, Michele Kang's net worth is estimated to be around $200 million in 2025. This impressive figure is a result of her successful ventures and investments in the biotechnology sector. Kang’s salary varies depending on the performance of her companies, but she is known to receive substantial compensation as the CEO of Cognate Health.
Career, Business and Investments
Michele Kang's career has been nothing short of remarkable. After completing her education, she entered the business world, eventually founding Cognate Health. Under her leadership, the company has grown exponentially, becoming a leader in cell and gene therapy solutions. Kang is also an active investor, frequently seeking out innovative startups in the biotech realm to support.
In addition to her work at Cognate Health, Kang serves on several boards and is involved in various philanthropic efforts, particularly those that promote education and health accessibility. Her entrepreneurial journey continues to inspire many aspiring business leaders.
Yongmee Michele Kang (born 1 June 1959 ) is an American businesswoman, philanthropist, investor, and owner of multiple professional football (soccer) teams. She became vice president of the e-Business unit of Northrop Grumman in 2000. Since 2006, she has been on the board of directors at Rexahn Pharmaceuticals.
In 2008, she founded Cognosante, a medical technology company, and Cognosante Ventures, a venture capital firm.
Social Network
Michele Kang maintains a presence on various social media platforms, although she is more reserved compared to other public figures. You can typically find her on LinkedIn where she shares insights related to her professional life, business achievements, and thoughts on industry advancements.
Education
Michele Kang holds a Bachelor’s degree in biology from the University of California, Berkeley, where she laid the foundation for her career in the life sciences. Furthering her education, she obtained an MBA from Harvard Business School, equipping her with essential skills in business management and strategy. Her educational background has played a pivotal role in her success in the competitive world of biotechnology.
